Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9306)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 24, 2020 (publication date) through May 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Feeney L, Harley IJ, McCluggage WG, Mullan PB, Beirne JP. Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes. World J Clin Oncol 2020; 11(11): 868-889 [PMID: 33312883 DOI: 10.5306/wjco.v11.i11.868] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i11/868.htm |
| Number | Citing Articles |
| 1 |
Shreya A Sahu, Deepti Shrivastava. A Comprehensive Review of Screening Methods for Ovarian Masses: Towards Earlier Detection. Cureus 2023; doi: 10.7759/cureus.48534
|
| 2 |
Shruti Jain, Nimrah Nadeem, Benjamin Ulfenborg, Maria Mäkelä, Shamima Afrin Ruma, Joonas Terävä, Kaisa Huhtinen, Janne Leivo, Björg Kristjansdottir, Kim Pettersson, Karin Sundfeldt, Kamlesh Gidwani. Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer. International Journal of Cancer 2022; 151(7): 1175 doi: 10.1002/ijc.34111
|
| 3 |
Louise Faaborg, Rikke Fredslund Andersen, Sara WC Wen, Caroline B Thomsen, Louise Raunkilde, Torben Frøstrup Hansen, Lars Henrik Jensen, Karina Dahl Steffensen, Anders Jakobsen. Prognostic impact of early ctDNA dynamics during chemotherapy of metastatic cancer. Future Oncology 2023; doi: 10.2217/fon-2023-0111
|
| 4 |
Naoki Kawahara, Ryuji Kawaguchi, Keita Waki, Tomoka Maehana, Shoichiro Yamanaka, Yuki Yamada, Fuminori Kimura. The prognosis predictive score around primary debulking surgery (PPSP) improves diagnostic efficacy in predicting the prognosis of ovarian cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-27333-1
|
| 5 |
O. N. Guskova, I. A. Alliluev, E. V. Verenikina, V. V. Polovodova, M. A. Rogozin, T. Yu. Myagkova, M. L. Adamyan, O. E. Zhenilo, N. M. Abdullaeva, M. R. Tsandekova, N. D. Ushakova, D. S. Kutilin. Changes in urine metabolite concentration as a minimally invasive marker of ovarian serous adenocarcinoma. Russian Journal of Biotherapy 2023; 22(3): 43 doi: 10.17650/1726-9784-2023-22-3-43-50
|
| 6 |
Christine Pampeno, Silvana Opp, Alicia Hurtado, Daniel Meruelo. Sindbis Virus Vaccine Platform: A Promising Oncolytic Virus-Mediated Approach for Ovarian Cancer Treatment. International Journal of Molecular Sciences 2024; 25(5): 2925 doi: 10.3390/ijms25052925
|
| 7 |
I Made Darmayasa, Ni Luh Putu Padmawati. Quality of Life of Patients with Advanced Stage Ovarian Cancer from Sanglah Hospital Denpasar: Serial Case Report. European Journal of Medical and Health Sciences 2022; 4(3): 16 doi: 10.24018/ejmed.2022.4.3.1300
|
| 8 |
Diana Žilovič, Ieva Vaicekauskaitė, Rūta Čiurlienė, Rasa Sabaliauskaitė, Sonata Jarmalaitė. Uterine Cavity Lavage Mutation Analysis in Lithuanian Ovarian Cancer Patients. Cancers 2023; 15(3): 868 doi: 10.3390/cancers15030868
|
| 9 |
Naoki Kawahara, Ryuji Kawaguchi, Tomoka Maehana, Shoichiro Yamanaka, Yuki Yamada, Hiroshi Kobayashi, Fuminori Kimura. The Endometriotic Neoplasm Algorithm for Risk Assessment (e-NARA) Index Sheds Light on the Discrimination of Endometriosis-Associated Ovarian Cancer from Ovarian Endometrioma. Biomedicines 2022; 10(11): 2683 doi: 10.3390/biomedicines10112683
|
| 10 |
Dimitra Stergiopoulou, Athina Markou, Lydia Giannopoulou, Paul Buderath, Ioanna Balgkouranidou, Nikolaos Xenidis, Stylianos Kakolyris, Sabine Kasimir-Bauer, Evi Lianidou. Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients. Cancers 2022; 14(15): 3790 doi: 10.3390/cancers14153790
|
| 11 |
Abigél Balla, Jong Bhak, Orsolya Biró. The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer. Molecular and Cellular Probes 2022; 66: 101871 doi: 10.1016/j.mcp.2022.101871
|
| 12 |
James P. Beirne, Alan Gilmore, Caitríona E. McInerney, Aideen Roddy, W. Glenn McCluggage, Ian J.G. Harley, M. Abdullah Alvi, Kevin M. Prise, Darragh G. McArt, Paul B. Mullan. A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancer. Computational and Structural Biotechnology Journal 2022; 20: 3359 doi: 10.1016/j.csbj.2022.06.016
|
| 13 |
Jin Wang, Xiaoyan Pan, Junyu Zhang, Qingqing Zhang, Yanchen Li, Weiwei Guo, Jie Zhang. Active molecule-based theranostic agents for tumor vasculature normalization and antitumor efficacy. Chinese Chemical Letters 2024; 35(8): 109187 doi: 10.1016/j.cclet.2023.109187
|
| 14 |
Somayeh Hashemi Sheikhshabani, Zeinab Amini‐Farsani, Nesa Kazemifard, Parastoo Modarres, Zahra Amini‐Farsani, Mir Davood Omrani, Soudeh Ghafouri‐Fard. Meta‐analysis of microarray data to determine gene indicators involved in the cisplatin resistance in ovarian cancer. Cancer Reports 2023; 6(12) doi: 10.1002/cnr2.1884
|
| 15 |
Naoki Kawahara, Shoichiro Yamanaka, Sumire Sugimoto, Junya Kamibayashi, Kyohei Nishikawa, Ryuji Kawaguchi, Fuminori Kimura. The Prognosis Predictive Score around Neo Adjuvant Chemotherapy (PPSN) Improves Diagnostic Efficacy in Predicting the Prognosis of Epithelial Ovarian Cancer Patients. Cancers 2023; 15(20): 5062 doi: 10.3390/cancers15205062
|
| 16 |
Shoichiro Yamanaka, Naoki Kawahara, Ryuji Kawaguchi, Keita Waki, Tomoka Maehana, Yosuke Fukui, Ryuta Miyake, Yuki Yamada, Hiroshi Kobayashi, Fuminori Kimura. The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy. Diagnostics 2022; 12(5): 1212 doi: 10.3390/diagnostics12051212
|